Dyne Therapeutics, Inc.
DYN
$25.70
-$0.26-1.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -61.07% | -4.76% | -25.03% | -11.24% | -70.28% |
| Total Depreciation and Amortization | 11.33% | 9.56% | 15.78% | 19.41% | 26.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 48.96% | 3.48% | 10.88% | 37.96% | 79.02% |
| Change in Net Operating Assets | 481.42% | -944.50% | -122.44% | -58.61% | 32.95% |
| Cash from Operations | -37.57% | -36.86% | -32.60% | -21.64% | -72.60% |
| Capital Expenditure | -2,423.33% | 77.47% | 54.98% | -7,483.00% | 93.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -148.01% | -189.01% | 109.82% | 1.93% | -43.20% |
| Cash from Investing | -170.79% | -264.06% | 106.13% | -95.67% | -39.38% |
| Total Debt Issued | -38.57% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -62.63% | -99.07% | 10,392.85% | 1,109.82% | -99.48% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -42.34% | -95.00% | 11,752.72% | 1,106.77% | -73.47% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -699.23% | -481.05% | 431.01% | 216.52% | -96.18% |